baber/WOPTO huggingface dataset:
Patent CA-2538293-A1 (CA)
Title: Substances k01-0509 and process for producing the same
Inventor: ABE AKIO
IPC: C12R1/465
Filed: 2004-02-09
Abstract: A microorganism belonging to the genus Streptomyces and being capable of producing substance K01-0509-A1 and/or substance K01-0509-A2 is cultured in a medium. Then, the substance K01-0509-A1 and/or the substance K01-0509-A2 having been thus accumulated in the liquid culture medium are collected from the medium. It is expected that the obtained substances are efficacious as drugs which are selectively effective on pathogenic gram-negative bacteria having the type III secretion system.
Patent CA-2540024-A1 (CA)
Inventor: SPILSBURY CHRISTOPHER GEOFFREY
IPC: F25J1/02
Filed: 2004-09-14
Abstract: Gas is liquefied by a method comprising cooling a feed gas (1) by a first refrigeration system (45, 47, 49, 51, 53, 21, 55, 57, 23, 21) in a first hea t exchange zone (21) and withdrawing a substantially liquefied feed stream (25 ) therefrom, further cooling the substantially liquefied feed stream in a seco nd heat exchange zone (27) by indirect heat exchange with one or more work- expanded refrigerant streams (29) provided by a second refrigeration system (81, 83, 59, (i) 61, 63, 65, 31, 29, 27, 67 & (ii) 69, 71, 73, 75, 77, & amp; 79, 63), and withdrawing therefrom a further cooled, substantially liquefied fee d stream (33). At least one (29) of the one or more work-expanded refrigerant streams is provided by compressing (83) one or more refrigerant gases (81) t o provide a compressed refrigerant stream (59), cooling all or a portion (61) of the compressed refrigerant stream (59) in a third heat exchange zone (63) to provide a cooled, compressed refrigerant stream (65), and work expanding (31 ) the cooled, compressed refrigerant stream (65) to provide one of the one or more work-expanded refrigerant streams (29). The flow rate of a work-expande d refrigerant stream (29) in the second heat exchange zone (27) is less than t he total flow rate of one or more work-expanded refrigerant streams (67 + 77 = 79) in the third heat exchange zone (63) or additional refrigeration duty is provided to the third heat exchange zone by a third refrigeration system (Fi g. 9; 911, 913, 905, 903, 907, 909, 903).
Patent CA-2542223-A1 (CA)
Inventor: CLARK SCOTT L
IPC: B23Q3/06
Filed: 2006-04-06
Abstract: Adjustable holding systems, as well as methods of using, may include a fixed base adapted for use on a work surface, the fixed base having a rear actuated clamp assembly secured thereto. Other systems and methods may include one or more bases adapted for use on a work surface; and a guide assembly removably securable to the one or more bases, wherein the guide assembly provides infinite vertical adjustability which can be retained without clamping. Yet other systems and methods may include a portable base securable to a work surface, the portable base having a portable base opening.
Patent CA-2542887-A1 (CA)
Inventor: BOSCOLO ROSANNO
IPC: A23L35/00
Filed: 2004-10-18
Abstract: The present invention relates to a filled food product (7), the semi-processed product (1) from which the food product is obtained and the methods and plant (30) for producing the same. The semi-processed product (1) consists of a single whole piece of dough. Such dough consists of a partially cooked mixture of water and flour. The semi-processed product (1) is formed into a goblet-like shape, has an axis (c-c) and an opening which defines a plane (.pi.). The axis (c-c) is inclined and oblique with respect to the plane (.pi.) of the opening. The finished food product (7) is obtained by the filling and the cooking of the semi-processed product (1).
Patent CA-2545484-A1 (CA)
Title: Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin
Inventor: SCHUMACHER ANDREAS
IPC: C07D239/00
Filed: 2004-11-17
Abstract: Process for the preparation of tetrahydrobiopterin from neopterin and/or 6-substituted pterins with an improved yield and a high stereoselectivity. Also disclosed herein are novel individual intermediates prepared in the preparation of tetrahydrobiopterin, such as selectively protected neopterin useful for the preparation of tetrahydrobiopterin.
Patent CA-2545611-A1 (CA)
Inventor: WAYBRIGHT BERT J
IPC: A01K1/01
Filed: 2006-05-02
Abstract: Animal waste is removed from a barn floor by moving a trolley in a first direction adjacent a first trough in the floor. As the trolley moves in the first direction: a blade extending from the trolley scrapes the waste into a region adjacent the trough; rotating paddles on the trolley drive the waste from the region into the trough; and a plow on the trolley that extends into the trough drives the waste toward one end of the trough for removal. Alternatively water drives the waste in the trough in the first direction. When the trolley moves away from the one end, the blades scrape the waste toward the region and the paddles drive the waste into the trough, but the plow is idle because the plow pivots to ride on top of the waste.
Patent CA-2545725-A1 (CA)
Inventor: SPAREY TIMOTHY JASON
IPC: C07D473/24
Filed: 2004-11-12
Abstract: Compounds of formula (I); which are useful as therapeutic compounds, particularly in the treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1).
Patent CA-2550006-A1 (CA)
Inventor: MOLAISON CHRIS ANTHONY
IPC: C09D4/00
Filed: 2004-12-08
Abstract: The present invention is directed to curable acrylate coating compositions and coated articles resulting therefrom. The curable acrylate coating composition comprises at least two polyfunctional acrylate derivatives, at least one photoinitiator and at least one nanoscale filler.
Patent CA-2550559-A1 (CA)
Title: A method and system for avoiding amplified spontaneous emission loops in an optical network
Inventor: CARPINI WALTER JOSEPH
IPC: H04B10/18
Filed: 2006-06-14
Abstract: The invention provides an effective method and system for avoiding amplified spontaneous emission (ASE) loops in optical communication networks. The method deploys optical seams as well as a unique signature for a wavelength instance for achieving an effective solution that is resilient to errors and failures that may occur on the system both during service creation and normal operation.
Patent CA-2552221-A1 (CA)
Title: Donepezil formulations
Inventor: DUNDON JOSEPHINE
IPC: A61K31/445
Filed: 2004-12-23
Abstract: Donepezil formulations, including amorphous donepezil or pharmaceutically acceptable salts thereof; sustained-release formulations; and donepezil sprinkle formulations are disclosed.
Patent CA-2552330-A1 (CA)
Inventor: CHEUNG ERIC
IPC: H04L69/14
Filed: 2006-07-19
Abstract: A method and apparatus for controlling end-to-end media on packet networks such as Voice over Internet Protocol (VoIP) and Service over Internet Protocol (SoIP) networks are disclosed. The present method provides an algorithm to be run by channel terminations such that the media channel is controlled by compositional actions. For example, the servers that terminate the media channel are able to respond on behalf of an endpoint in order to effect the appropriate compositional action. The present method also enables each direction of a bi-directional media channel to be controlled independent of the media channel in the opposite direction.
Patent CA-2553191-A1 (CA)
Title: A device for raising, transportation and releasing crustacea juveniles and use of the device
Inventor: FROYLAND T KJETIL
IPC: A01K61/00
Filed: 2005-01-10
Abstract: The present invention relates to a device for raising, transporting and releasing on a sea bed (50) crustacea juveniles which are in a housing secti on (1), the housing section (1) being adapted for connection to an emigration device (60, 80, 100) and the emigration device (60, 80, 100) being provided with at least one bore (70, 86) arranged to form an open path between an are a near the surface of the sea bed (50) and a tubular element (10) disposed in a cut-out (12) in the housing section (1).
Patent CA-2554595-A1 (CA)
Title: Device and method for controlling in-vivo pressure
Inventor: SHMULEWITZ ASCHER
IPC: A61M1/12
Filed: 2005-02-03
Abstract: A differential pressure regulating device is provided for controlling in-vivo pressure in a body, and in particularly in a heart. The device may include a shunt being positioned between two or more lumens in a body, to enable fluids to flow between the lumens, and an adjustable flow regulation mechanism being configured to selectively cover an opening of the shunt, to regulate the flow of fluid through the shunt in relation to a pressure difference between the body lumens. In some embodiments a control mechanism coupled to the adjustable flow regulation mechanism may be provided, to remotely activate the adjustable flow regulation mechanism.
Patent CA-2555153-A1 (CA)
Title: Premix burner with a swirl generator delimiting a conical swirl space and having sensor monitoring
Inventor: BRUNNER PHILIPP
IPC: F23N5/02
Filed: 2005-02-08
Abstract: A premix burner is described, with a swirl generator which delimits a conical swirl space (1) and provides at least two conical part shells (2, 3) which are arranged, offset to one another, along a burner axis (A), mutually enclose in each case air inlet slits (4) running longitudinally with respect to the burner axis (A) and have in combination a conically widening premix burner outer contour having a maximum outside diameter (A max) which narrows axially into a region with a minimum outside diameter (A min) .     The invention is distinguished in that at least one conical part shell (2, 3) provides, in the region between the maximum and the minimum outside diameter, a reception unit (7) which deviates from the conically widening premix burner outer contour and locally elevates the premix burner outer contour radially outward and which has a maximum radial extent (R max) which is dimensioned smaller than half the maximum outside diameter (A max) of the premix burner outer contour, and in that, within the reception unit (7), at least one hollow duct (8) is provided, with at least one duct orifice (9) facing away from the swirl space (1) and with a duct longitudinal extent which runs essentially parallel to the burner axis (A).
Patent CA-2556463-A1 (CA)
Title: Dihydropyridinone derivatives
Inventor: PERNERSTORFER JOSEF
IPC: C07D409/12
Filed: 2005-02-05
Abstract: The invention relates to novel dihydropyridinone derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.
Patent CA-2557868-A1 (CA)
Inventor: GLEITMAN DANIEL D
IPC: E21B4/00
Filed: 2005-03-03
Abstract: Methods and apparatuses for drilling a borehole are disclosed. An electric motor electrically and mechanically coupled to a wired drill pipe is provided.  The electric motor couples to a shaft that rotates when power is supplied to the electric motor. The shaft is couplable to a drill bit. The wired drill pipe transfers electricity to the electric motor from the surface. Operation of the electric motor rotates the shaft. The drill bit wears away earth to form the borehole in the earth.
Patent CA-2559601-A1 (CA)
Inventor: BEN-SASSON SHMUEL A
IPC: A23L19/00
Filed: 2005-03-14
Abstract: Disclosed herein is a seasoning composition which imparts a pleasant flavor to foods, or hides unpleasant food flavors with reduced sodium when compared to table salt and other salt substitutes. The seasoning composition is also a dietary supplement which provides potassium to the diet. The seasoning composition is used in a methods of seasoning food or drink with the seasoning composition. The seasoning composition is also used in methods for administering a low sodium diet and methods of administering potassium in a palatable form.
Patent CA-2560074-A1 (CA)
Title: Combinatorial protein library screening by periplasmic expression
Inventor: GEORGIOU GEORGE
IPC: C40B40/02
Filed: 2005-03-18
Abstract: The invention overcomes the deficiencies of the prior art by providing a rapid approach for isolating binding proteins capable of binding small molecules and peptides. In the technique, libraries of candidate binding proteins, such as antibody sequences, may be expressed in the periplasm of gram negative bacteria with at least one target ligand. In clones expressing recombinant polypeptides with affinity for the ligand, the ligand becomes bound and retained by the cell even after removal of the outer membrane, allowing the cell to be isolated from cells not expressing a binding polypeptide with affinity for the target ligand. The target ligand may be detected in numerous ways, including use of direct fluorescence or secondary antibodies that are fluorescently labeled, allowing use of efficient screening techniques such as fluorescence activated cell sorting (FACS). The approach is more rapid and robust than prior art methods and avoids problems associated with the outer surface~ expression of ligand fusion proteins employed with phage display.
Patent CA-2561698-A1 (CA)
Title: Method to assess a person's knowledge of a subject area
Inventor: TASHIRO JAY SHIRO
IPC: G09B7/00
Filed: 2005-03-31
Abstract: A method to assess a person's knowledge of a subject area is disclosed. The method prepares a plurality of test questions relating to the subject area, selects (n) first test questions from that plurality of test questions, and propounding each of these first test questions to the subject. The subject answers zero or more of the propounded first test questions. The method then determines for each of the propounded first test questions if that first test question was correctly answered, calculates a first score by dividing the number of correctly answered first questions by (n), sets an Excellent Threshold and an Excellent Points Assignment, and determines if the first score is greater than or equal to that Excellent Threshold, the method allocates the Excellent Points Assignment and assigns an End Of Pathway designation of Excellent.
Patent CA-2562554-A1 (CA)
Inventor: LESUR BRIGITTE
IPC: C07D307/46
Filed: 2005-04-13
Abstract: The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions of compounds of Formula (A): wherein Ar, X, Y, R1, R2, R3, and q are as defined herein; and their use in the treatment of diseases, including treatment of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder ("ADHD"), enhancing function in disorders associated with hypofunctionality of the cerebral cortex, including, but not limited to, depression, schizophrenia, fatigue, in particular, fatigue associated with neurologic disease, such as multiple sclerosis, chronic fatigue syndrome, and improvement of cognitive dysfunction.
Patent CA-2563031-A1 (CA)
Inventor: COHEN DAVID L
IPC: E04B1/35
Filed: 2005-02-18
Abstract: The system for manufacturing standard size dwellings comprises a network of facilities, sited to maximize the efficiency of the product and materials flows. In particular, one or more manufacturing facilities are used to manufacture subassemblies and supply materials for use in assembling a standard size dwelling in a factory environment. These manufactured subassemblies and materials are transported to one or more satellite manufacturing facilities, each of which are located proximate to a location where a large number of dwellings are to be built. The satellite manufacturing facilities function to integrate the received subassemblies and materials together to create a standard size dwelling, which is then transported to the foundation where the dwelling is to be sited. The satellite manufacturing facilities can optionally manufacture subassemblies, such as a roof subassembly, where appropriate as part of the dwelling assembly process.
Patent CA-2565870-A1 (CA)
Inventor: KAVANAU CHRISTOPHER L
IPC: G06V10/24
Filed: 2005-05-06
Abstract: L dimensional images are trained, mapped, and aligned to an M dimensional topology to obtain azimuthal angles (112) . The aligned L dimensional images are then trained and mapped to an N dimensional topology to obtain 2 (N) vertex classifications (113). The azimuthal angles and the 2 (N) vertex classifications are used to map L dimensional images into O dimensional images (114).
Patent CA-2567578-A1 (CA)
Inventor: PORAT YAEL
IPC: C12N5/078
Filed: 2005-06-01
Abstract: A method is provided for use with extracted blood, including (a) applying blood to a first gradient suitable for selecting first-pass cells having a density less than 1.077 g/ml; (b) applying the first-pass cells to a second gradient suitable for selecting second-pass cells having a density between 1.055 and 1.074 g/ml; (c) increasing the number of cells having a density between 1.055 and 1.074 g/ml, by culturing the second-pass cells for a period lasting between 3 and 30 days; and (d) identifying endothelial progenitor cells in the cultured cells. Other embodiments are also described.
Patent CA-2568043-A1 (CA)
Title: Apparatus and method for sending and receiving digital rights objects in converted format between device and portable storage
Inventor: KIM TAE-SUNG
IPC: H04L29/06
Filed: 2005-05-20
Abstract: An apparatus and method for sending and receiving a digital rights object (RO) in a converted format between a device and a portable storage are provided.  The device includes a transceiver module receiving a RO from a rights issuer, an RO converter module converting the RO received by the transceiver module into a format for communication with a portable storage, an interface module for connection with the portable storage, a public-key encryption module authenticating with the portable storage connected through the interface module, a session key generation module generating a session key shared with the authenticated portable storage, and a digital rights management (DRM) agent providing the RO in the format converted by the RO converter module to the portable storage and receiving a RO in the converted format from the portable storage. The device converts the format of the RO to communicate with the portable storage.
Patent CA-2571922-A1 (CA)
Title: Modified blackjack game
Inventor: SORGE NICHOLAS
IPC: A63F3/00
Filed: 2005-06-30
Abstract: A method for playing a modified blackjack game between a dealer and at least one player. Each player places an first wager, the outcome of which is determined by conventional rules of blackjack. Players may optionally place an additional wager corresponding to a predicted total point value or point value range of an initial hand of two cards dealt to the player. After the dealer has dealt a player a second card from one or more standard decks of playing cards, an actual total point value is computed for the two-card hand of that player. If an actual total point value is equal to or in a range of a predicted total point value or range, a player wins a predetermined multiple of an amount of the additional wager. A second predetermined multiple may be paid if a player's hand includes two cards of the same suit.
Patent CA-2572439-A1 (CA)
Title: Immunostimulatory sirna molecules and uses therefor
Inventor: JUDGE ADAM
IPC: A61K31/713
Filed: 2005-06-30
Abstract: The present invention provides siRNA molecules and methods of using such siRNA  molecules to modulate an immune response and to silence expression of a target gene.
Patent CA-2584355-A1 (CA)
Title: Fuel cell component
Inventor: SCHUISKY MIKAEL
IPC: H01M8/02
Filed: 2005-11-21
Abstract: A fuel cell component, such as an interconnect for solid oxide fuel cells, consists of a metallic substrate, such as stainless steel, and a coating, which in turn comprises at least one metallic layer and one reactive layer.  The fuel cell component is produced by providing the different layers, preferably by coating, and thereafter oxidising to accomplish a conductive surface layer comprising a complex metal oxide structure.
Patent CA-2584646-A1 (CA)
Inventor: GLEAVE MARTIN E
IPC: A61K31/7088
Filed: 2005-11-22
Abstract: Agents that perturb the EGF signaling pathway and that are known to be useful in the treatment of cancer are found also to result in increased expression of the protein clusterin. Since clusterin can provide protection against apoptosis, this secondary effect detracts from the efficacy of the therapeutic agent. This is overcome using a combination of an agent that has known therapeutic efficacy against the cancer to be treated by perturbation of the EGF signaling pathway and that stimulates expression of clusterin as a secondary effect, and an oligonucleotide that is effective to reduce the amount of clusterin in cancer cells. For example, the agent may be an antibody specific for HER-2, a small molecule inhibitor of HER-2, an antisense oligonucleotide specific for HER-2, or a peptide agent capable of interfering with HER-2 protein. The oligonucleotide may be an antisense oligonucleotide or an RNAi oligonucleotide.
Patent CA-2585269-A1 (CA)
Title: Method, system, and software for analyzing pharmacovigilance data
Inventor: KINGAN ROBERT J
IPC: G16H10/20
Filed: 2005-10-25
Abstract: A computer-implemented method of analyzing a dataset of pharmacovigilance data, includes determining a sample size-independent measure of association between two conditions of interest in the dataset of pharmacovigilance data;  using a hypergeometric distribution to determine a measure of statistical unexpectedness between the conditions of interest in said dataset, wherein the distribution is based on an urn model under a hypothesis that the conditions are statistically independent; and displaying the measure of association with the measure of the statistical unexpectedness to identify a significant association between conditions of interest.
Patent CA-2587063-A1 (CA)
Inventor: CEDERMARKER MATS
IPC: A47G29/12
Filed: 2004-10-29
Abstract: A letter box (10) comprises an upper part (10a, 20) with an open end, a lower part (10b, 21) having a movable bottom part (22) for optionally sealing an open end of the lower part, a door (23) hinged to the upper part (10a, 20), a front (25) with at least one front opening (26, 27), a back (24, 34), and sides (28, 33) connecting the front and back of the letter box, the letter box (10) having fastening means (21a, 36) for enabling the optional connection of an expansion part (30) to the lower part (10b, 21) for increasing the post storing capability of the letter box (10).
Patent CA-2589779-A1 (CA)
Inventor: HONOLD KONRAD
IPC: C07D471/04
Filed: 2005-12-22
Abstract: Objects of the present invention are the compounds of formula (I) their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
Patent CA-2591083-A1 (CA)
Title: Medicaments for the treatment or prevention of fibrotic diseases
Inventor: GRAUERT MATTHIAS
IPC: A61P43/00
Filed: 2005-12-21
Abstract: The present invention relates to the use of indolinones of general formula (I) substituted in the 6 position, wherein R1 to R5 and X are defined as in claim 1, the isomers and the salts thereof, particularly the physiologically acceptable salts thereof, as a medicament for the prevention or treatment of specific fibrotic diseases.